BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23900766)

  • 1. Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
    Sandlund JT; Hudson MM; Kennedy W; Onciu M; Kastan MB
    Pediatr Blood Cancer; 2014 Feb; 61(2):360-2. PubMed ID: 23900766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.
    Lervat C; Auperin A; Patte C; Méchinaud F; Leverger G; Nelken B; Bertrand Y; Baruchel A; Coze C; Munzer M; Lacombe MJ; Bergeron C
    Pediatr Blood Cancer; 2014 Mar; 61(3):473-8. PubMed ID: 23970385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
    Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Gerrard M; Cairo MS; Weston C; Auperin A; Pinkerton R; Lambilliote A; Sposto R; McCarthy K; Lacombe MJ; Perkins SL; Patte C;
    Br J Haematol; 2008 Jun; 141(6):840-7. PubMed ID: 18371107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma].
    Forns M; Javier G; Estella J; Fernández-Delgado R; Gallego S; García-Miguel P; Indiano JM; Navajas A; Pardo N;
    Med Clin (Barc); 2007 May; 128(17):641-6. PubMed ID: 17537360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
    Atra A; Gerrard M; Hobson R; Imeson JD; Ashley S; Pinkerton CR
    Br J Cancer; 1998 Jun; 77(12):2281-5. PubMed ID: 9649146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H; Bajciova V; Nemec J; Al Shemmari S; Al Awadi S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):103-10. PubMed ID: 12554521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
    Moleti ML; Al-Jadiry MF; Shateh WA; Al-Darraji AF; Mohamed S; Uccini S; Piciocchi A; Foà R; Testi AM; Al-Hadad S
    Leuk Lymphoma; 2019 May; 60(5):1224-1233. PubMed ID: 30997873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary lacrimal sac non-Hodgkin's lymphoma in a child.
    Köksal Y; Kiratli H; Varan A; Akçören Z; Büyükpamukçu M
    Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1551-3. PubMed ID: 16085321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.
    Bertz H; Zeiser R; Lange W; Fetscher S; Waller CF; Finke J
    Ann Oncol; 2004 Sep; 15(9):1419-24. PubMed ID: 15319249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
    Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
    Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Demyelinating Disease; What Lies Beneath?
    Rabah F; Elmanzalawy A; Bhuyan D; El-Banna N; Beshlawi I
    Indian J Pediatr; 2016 Apr; 83(4):365-7. PubMed ID: 26204979
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
    Yoon JH; Kang HJ; Kim H; Lee JW; Park JD; Park KD; Shin HY; Ahn HS
    J Korean Med Sci; 2012 Nov; 27(11):1378-84. PubMed ID: 23166421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
    Pytlík R; Belada D; Kubáčková K; Vášová I; Kozák T; Pirnos J; Bolomská I; Matuška M; Přibylová J; Campr V; Burešová L; Sýkorová A; Berková A; Klener P; Trněný M;
    Leuk Lymphoma; 2015 Jan; 56(1):57-64. PubMed ID: 24628294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
    Acquatella G; Insausti CL; García R; Gómez R; Hernández M; Carneiro M; Santos S; Nouel A
    Pediatr Blood Cancer; 2004 Oct; 43(5):580-6. PubMed ID: 15382276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
    Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
    Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.